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Objective: To evaluate stability and integrity of bi-layer and three-layer collagen-hydroxyapatite (C-HA)
osteochondral scaffolds in a human cadaveric knee exposed to continuous passive motion (CPM) with
and without loading and the role of added ﬁbrin glue to improve the press-ﬁt ﬁxation of C-HA scaffolds.
Design: Osteochondral lesions (2.0  1.5 cm) were chiseled out on both condyles and trochlea in eight
human cadaveric knees. A total of 24 bi-layer (5 mm, four in each condyle) or three-layer C-HA scaffolds
(8 mm, eight in the trochlea, four in each condyle) were ﬁrst press-ﬁt implanted and underwent testing
with CPM, 90 cycles, 0e90. The second set of 24 scaffolds was implanted in cleaned lesions with the
addition of ﬁbrin glue. Two knees with ﬁbrin glue ﬁxation were additionally exposed to 15 kg loading,
with 30 cycles of CPM, 0e30. Then, the knees were reopened and the scaffolds were evaluated using
semi-quantitative Drobnic and modiﬁed Bekkers scores.
Results: All but two scaffolds remained in the lesions site throughout CPM. Two implants failed: both
were bi-layer osteochondral scaffolds, press-ﬁt implanted at the lateral femoral condyle (LFC). A statis-
tically signiﬁcant difference was obtained between press-ﬁt and ﬁbrin glue implants with both Drobnic
(2.9  0.7 vs 4.3  0.1, P < 0.0005) and Bekkers (3.3  1.0 vs 5.0  0.1, P < 0.0005) scores. Additional knee
loading did not affect ﬁbrin glue scaffold ﬁxation or integrity.
Conclusion: This cadaveric study showed ﬁbrin glue notably improved bi-layer or three-layer C-HA
scaffold press-ﬁt ﬁxation regardless of lesion location. It is therefore recommended that ﬁbrin glue be
used during surgery to improve early post-operative C-HA scaffold stability and integrity.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Cartilage lesions have a high impact on society1e4: the greater
emphasis on physical activity in all age groups is responsible for the
growing rate of these lesions, which are caused by trauma, overuse,
or favored by several factors such as misalignment, loss of meniscal
tissue, joint instability or laxity5,6. Thus, several treatments have
been proposed, from conservative to minimally-invasive injective
procedures, to surgical strategies to restore a correct biomechanical
balance and replace the damaged articular surface7e9. An increasing
awareness of the role of the subchondral bone in the10 has led to the
recent development of osteochondral scaffolds11. Among these, one: E. Kon, Rizzoli Orthopaedic
Clinic, Via di Barbiano, 1/10,
ternational. Published by Elsevier Lwas designed for large lesions: a nano-structured biomimetic
collagen/hydroxyapatite (C-HA) scaffold (MaioRegen: Fin-Ceramica
S.p.A., Faenza, Italy). Animal studies showedgood and similar results
when implanting the scaffold loadedwith autologous chondrocytes
or the scaffold alone12e14. Therefore, C-HA scaffold was introduced
into clinical practice as a non-cellular device. Positive clinical results
have been shown by isolated reports and short-term case series and
a recent study seem to conﬁrm the good outcome also at mid-
term15e17. These promising ﬁndings have been strengthened by
results inmore challenging lesions, such as large complex defects or
even in patients affected by unicompartmental osteoarthritis18e20.
However, there are some drawbacks: not all patients beneﬁt from
this procedure, post-operative adverse events have been reported,
and imaging analysis shows controversial ﬁndings17. An Magnetic
Resonance Imaging (MRI) study byKon et al. that evaluated the early
stability of implanted scaffolds21 documented partial detachment in
13%, a complete ﬁlling in only 67%, and a complete integration of thetd. All rights reserved.
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problems may be attributable either to the scaffold itself, or to the
implantation technique based on a press-ﬁt ﬁxation. Optimal sta-
bility of the implanted scaffold in the ﬁrst post-operative phase is of
the utmost importance particularly for a scaffold also designed for
the treatment of large and complex defects.
The aim of the study was therefore to evaluate the early post-
implantation scaffold stability, integrity, and ﬁxation strength in a
human cadaver knee exposed to continuous passive motion (CPM)
and to upgrade the implantation surgical technique. The hypothesis
was that the addition of ﬁbrin glue might provide a mechanical
beneﬁt and should be applied to improve the stability of the
implanted scaffold.
Methods
Permission for experimental work was granted by the National
Ethical Commission. The study set-up focused on the evaluation of
osteochondral scaffold stability, with or without the use of ﬁbrin
glue, during the operative procedure and duringmobilization in the
initial post-operative period in a previously developed human
cadaveric knee model22.
Osteochondral scaffold
The nano-structured biomimetic scaffold has a porous 3-D
three-layer composite structure. The cartilaginous layer, consist-
ing of type I collagen, has a smooth surface to favor joint ﬂow. The
intermediate tide-mark-like layer consists of type I collagen (60%)
and hydroxyapatite (HA) (40%), whereas the subchondral bone
layer consists of a mineralized blend of type I collagen (30%) and HA
(70%). Each layer is separately synthesized from an atelocollagen
aqueous solution (1% w/w) in acetic acid, isolated from equine
tendon. The ﬁnal construct is obtained by physically combining the
layers on top of aMylar sheet and ﬁnally freeze-drying and gamma-
sterilizing it at 25 KGray. Besides the three-layer scaffold, already
used in the clinical practice, a modiﬁed thinner bi-layer scaffold,
developed to increase the physical properties and to target shal-
lower cartilage lesions, was also tested. This scaffold consists of an
upper cartilaginous layer and a lower subchondral layer. For the
synthesis of the cartilaginous layer 200 g of 1 wt% type I collagen in
acid aqueous suspension (pH ¼ 3.5) were diluted with 200 mL ofFig. 1. The osteochondral scaffolds are implanted in condyle and trochlea lesions of 2  1.
coagulation in the clinical practice (B). Tips and tricks (C): if the press-ﬁt insertion is cumbers
with the subchondral bone, with consequent layer disruption bringing HA to the surface lev
metal instrument, “shoehorn” style.milli-Q water and were then precipitated by dropping NaOH solu-
tion 0.1 M up to the isoelectric point (pH 5.5). The ﬁbers were
subsequently washed three times with 300mL of milli-Q water. For
the synthesis of the subchondral layer a solution prepared with
3216 g of H3PO4 85%v/v and 700 mL of milli-Q water was mixed
with 300 g of 1 wt% type I collagen gel and dropped into 1100 mL of
basic suspension containing 1.554 g of Ca(OH)2 95 wt%, 0.2024 g of
MgCl2$6H2O and 55 mL of SBF to yield a composite Mg-HA/
Collagen material in the theoretical ratio of 70/30 wt% and Mg/Ca
mol¼ 5% in the crystal lattice. The precipitated ﬁbers werematured
for 1 h and subsequently washed three times with 400 mL of milli-
Q water. With the aim of stabilizing the scaffold and improving its
resistance to physiologic enzymatic attachment, each layer was
chemically cross-linked through a 48-h treatment at 4 C in 0.05 wt
% aqueous solution of 1,4-butanediol diglycidyl ether bis-epoxy
(BDDGE). Both scaffolds were precisely cut out with a scalpel un-
der caliper control to obtain homogeneous dimensions of 2 cm in
length and 1.5 cm in width.
Osteochondral lesion preparation
Eight fresh-frozen human cadaveric lower limbs, exarticulated
at the hip joint, were used in the study. They were removed from
the freezing storage 12 h prior experiments, and they were slowly
thawed and wormed up at ambient temperature, and kept at room
temperature (20 C) throughout the experiments for approximately
24 h. None of the limbs had detectable misalignment; ligaments,
menisci and cartilage in the knees were intact either on testing or
visual examination. The articular surfaces were exposed through a
medial parapatellar arthrotomy. The width of the central parts of
the articulating femoral surfaces was the following: medial femoral
condyle (MFC) from 24 to 33 mm, lateral femoral condyle (LFC)
from 29 to 35 mm, and the width of the articular surface on the
central part of the trochlea from 41 to 55 mm. Rectangular osteo-
chondral lesions were prepared with an osteotome under caliper
control to obtain precise defect areas of 2 times 1.5 cm (Fig. 1). More
in detail, the osteotome was used by performing a superﬁcial de-
limitation of the lesion ﬁrst, and subsequently a series of parallel
incisions alternated by perpendicular ones to delicately remove
fragments of the degenerated tissue leaving intact and perpendic-
ular defect shoulders. The process was repeated to obtain vertical
margins and gradually deepen the lesion area according to the5 cm (A), ﬁlled with blood to reproduce the initial phases of blood impregnation and
ome, to avoid deformation of the scaffold caused by friction of the lower scaffold layers
el, it can be helpful to accompany the insertion of the lower scaffold layers with a thin
Fig. 2. Fibrin glue is applied to the bottom part of the scaffold (upper left) and its margins (lower left); then after implantation it is applied to the hostescaffold interface and
implant surface (right).
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deﬁned according to the manufacturer’s recommendations: 8 mm
for three-layer C-HA scaffold and 5 mm for the bi-layer one. The
distributions were as follows: all trochlear lesions hosted only thick
three-layer scaffolds, whereas 4 MFC and 4 LFC were prepared for
the three-layer scaffolds, and 4 MFC and 4 LFC lesions were pre-
pared for the bi-layered ones. Just before each scaffold implantation
the lesions were ﬁlled with fresh blood (2e3 cc for each lesionwere
used) from a healthy donor to allow scaffolds to be soaked in blood
and reproduce the ﬁrst phases of blood impregnation and coagu-
lation in the clinical practice (Fig. 1).
Fixation of the collagen scaffold
A total of 24 scaffolds, eight on the trochlea and eight on each
condyle, were implanted ﬁrst; eight bi-layer and eight three-layer
scaffolds were equally distributed between both femoral con-
dyles, whereas all trochlear lesions were treated with the three-
layer scaffold. All scaffolds were press-ﬁt implanted and under-
went the CPM protocol. After evaluation, the ﬁrst set of scaffoldsFig. 3. The lower limb is strapped to a CPM device to perform 60 motion cycles of 90 s (
Steinman pin in the distal femur and the foot, and a force transducer is incorporated to cowas discarded and the lesions were cleaned. The second set of 24
scaffolds was implantedwith ﬁbrin glue (2 cc were sufﬁcient for the
ﬁxation of each scaffold) before CPM. Fibrin glue (Tisseel, Baxter
AG, Vienna, Austria) was ﬁrst applied to the bottom, bone part, of
the scaffold and to the side walls. When the scaffold was implanted
it was impregnated with blood on the surface, and then care was
taken to apply ﬁbrin glue to the hostescaffold interface, and ﬁnally
a layer of ﬁbrin glue was applied to cover the scaffold surface
(Fig. 2).
Mobilization protocol
After ﬁxation of all three scaffolds, 5 ml of lactated Ringer’s
solution was added intra-articularly to moisten the joint surfaces.
The arthrotomy wound was closed in layers with interrupted su-
tures. The whole inferior extremity was then strapped to the CPM
device (Kinetec, Ormed GmbH & Co., Freiburg, Germany). One
motion cycle, extension (0) to ﬂexion (90) and to extension (0),
lasted 90 s (Fig. 3)22,23. After 60 cycles the arthrotomy wound was
reopened to evaluate the scaffold’s appearance. This sequence was0e90e0) (left). To simulate partial loading elastic straps are stretched between a
ntrol the 15 kg force applied between the two joints (right).
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with ﬁbrin glue. The scaffolds in the last two tested extremities
(both with three-layer scaffolds at the trochlea level, whereas the
bi-layer and three-layer scaffolds were alternated in the MFC and
LFC in the two knees) ﬁxed with ﬁbrin glue were additionally
exposed to 30 cycles of CPM loading to simulate the partial weight
bearing performed postoperatively. For this purpose, elastic straps
were stretched between a Steinman pin in the distal femur and the
foot. A force transducer was incorporated into the elastic system
(Fig. 3). Nominal loads of 15 kg were applied. The motion cycles
under loading were limited to: extension (0) ﬂexion (30) and
extension (0). The force deviations between ﬂexion and extension
were detected on the transducer, but excursions from the nominal
load did not exceed 20% in both directions. After completion of CPM
loading the knees were bent to 90 and reopened for the ﬁnal
evaluation.
Evaluation
The scaffolds were macroscopically evaluated by three surgeons
independently. A consensus of all three evaluators was reached as
the end result. The evaluation was performed with two semi-
quantitative scores. The Drobnic score22 combines three scales:
area coverage (range from 0 (>50% of area uncovered) to 5 (un-
changed)), integrity of the scaffold (range from 0 (>50% of scaffold
lost) to 5 (unchanged)), and manually tested endpoint ﬁxation
strength (range from 0 (total self-detachment) to 5 (not detach-
able)). The Bekkers score23 was modiﬁed by removing the last scale
dedicated to the endpoint ﬁxation strength measured quantita-
tively but a pulley-block system was not used, and consisted of:
outline attachment (range from 0 (100% circumference lost contact)
to 5 (unchanged)), area coverage (range from 0 (0%) to 5 (un-
changed)), and scaffold integrity (range from 0 (general scaffold
disorganization/cracks jeopardizing the ﬁxation) to 5
(unchanged)).
Strength testing was performed after the completion of 60 CPM
cycles, except in the last two extremities in which the ﬁxation
strength of the ﬁbrin glue implanted scaffolds was tested after the
completed loading protocol. The values obtained by the average of
the different scales for each score were used for the study purpose.Fig. 4. Implant appearance after CPM of press-ﬁt implantedStatistical analysis
The KolmogoroveSmirnov test was performed to test normality
of continuous variables. The logarithm transformation was used to
make the score distributions Normal and Homoscedastic. The
Repeated Measures General Linear Model (GLM) with the knee as
the random effect was performed to assess the differences at
different follow-up times. The GLM with the knee as the random
effect and the scaffold and site as the ﬁxed effect was performed to
test the inﬂuence on the scores of the scaffold in the different sites.
The ManneWhitney or the KruskaleWallis non-parametric test
evaluated by the Exact method for small samples were performed
to assess the between or among group differences. For all tests
P < 0.05 was considered signiﬁcant. All statistical analyses were
performed using SPSS v.19.0 (IBM Corp., Armonk, NY, USA).
Results
A statistically signiﬁcant difference was obtained between the
press-ﬁt and ﬁbrin glue implants in both Drobnic and Bekkers
scores (Fig. 4). In particular, the evaluation with the Drobnic score
showed: the press-ﬁt implants after CPM presented a value of 2.9
(CI 2.6e3.2), whereas the ﬁbrin glue implants reached a value of 4.3
(CI 4.3e4.3) (P< 0.0005). The Bekkers score was 3.3 (CI 2.8e3.7) for
press-ﬁt implants and 5.0 (CI 4.9e5.0) for ﬁbrin glue implants
(P < 0.0005). A further analysis was performed to evaluate site-
related differences in the Drobnic and Bekkers scores obtained
both by press-ﬁt and ﬁbrin glue implants: no statistically signiﬁcant
difference was found (press-ﬁt Drobnic score P ¼ 0.2; ﬁbrin glue
Drobnic score P ¼ 1.0; ﬁbrin glue Bekkers score P ¼ 1.0), and only a
tendency among press-ﬁt implants was seen with better Bekkers
scores in the MFC (P ¼ 0.076) (Fig. 5). Furthermore, no signiﬁcant
score differences were found comparing the results obtained for
the femoral condyles treated either with the three-layer or the bi-
layer scaffolds (press-ﬁt Drobnic score P ¼ 0.6; ﬁbrin glue Drobnic
score P ¼ 1.0; press-ﬁt Bekkers score P ¼ 0.8; ﬁbrin glue Bekkers
score P¼ 1.0). The only observed difference was found by analyzing
the effect of site and scaffold together: GLM showed that whereas
in the MFC the two scaffolds had similar results, signiﬁcantly lower
scores were documented for LFC treated with the bi-layer scaffold,only scaffolds (left) or press-ﬁt plus ﬁbrin glue (right).
Fig. 5. No statistically signiﬁcant difference in both Drobnic (upper part) and Bekkers
(lower part) scores (mean and 95% conﬁdence interval of the mean are reported) was
found among implants of the trochlea, MFC, and LFC; only a tendency among press-ﬁt
implants was seen with better Bekkers scores in the MFC (P ¼ 0.076).
Fig. 6. Similar results were obtained with the three-layer and the bi-layer scaffolds
(results are reported in box and whisker plots: the central bold line representing the
median, the box limits representing the quartiles, and the whiskers representing the
minimum and maximum values). The only difference was found by analyzing the effect
of site and scaffold together with GLM: whereas in the MFC the two scaffolds had
similar results, lower scores were documented for LFC treated with the bi-layer scaf-
fold, both with the Drobnic (upper right) and Bekkers (lower right) scores (both
P ¼ 0.04).
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(Fig. 6). Loading in the two knees of the ﬁbrin glue group and
subsequent further mobilization did not affect the stability or
produce any detectable changes in the implanted scaffolds. Two
implants clearly failed: both cases were bi-phasic osteochondral
scaffolds, press-ﬁt implanted at the LFC, which presented a marked
disruptionwith delamination and layer dislodgement (Fig. 7). Some
ﬁnal considerations are not quantiﬁable and are reported as qual-
itative observations. The evaluation of the press-ﬁt implanted
scaffolds showed that the scaffold swelling due to its interaction
with biologic ﬂuids was not homogeneous, resulting in loss of
press-ﬁt at the cartilage level and exposure of the lower C-HA
structure directly at the intra-articular space. This problem may
appear already during the implantation and is worsened by CPM,
whereas it did not affect the ﬁbrin glue implanted scaffolds, not
even after loading. The scaffold pattern without ﬁbrin glue can be
summarized in two alterations that might be hypothesized as
failure mechanisms (Fig. 8). The ﬁrst one is the deformation,
bending and dislodgment of the entire scaffold; the second one is
the delamination with destruction of the cartilage layer. This was
never observed when using ﬁbrin glue, which stabilized the scaf-
fold both by increasing its internal layer cohesiveness and theintegration in the lesion area. The application of high amounts of
ﬁbrin glue did not jeopardize the scaffold. In fact, mobilization
caused the removal of the ﬁbrin glue layer in excess without
affecting the integrity and stability of the upper cartilage scaffold
layer. Finally, the bi-layer scaffold presented good handling prop-
erties and less deformation after interaction with biologic ﬂuids,
but this did not change the results in terms of implant stability and
integrity after CPM. Thus, the different locations and the different
scaffolds conﬁrmed that ﬁbrin glue makes a signiﬁcant mechanical
difference in all implant conditions.
Discussion
This ex-vivo study addressed press-ﬁt and press-ﬁt plus ﬁbrin
glue ﬁxation of two-layer and three-layer osteochondral scaffolds
in cadaver knees exposed to CPM with and without loading, to
Fig. 7. Two bi-phasic osteochondral press-ﬁt implanted scaffolds failed at the LFC: a marked disruption with delamination and layer dislodgement can be observed.
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improved the stability and integrity of the scaffolds irrespective of
lesion location or scaffold type. To the authors’ knowledge, this is
the ﬁrst study to speciﬁcally analyze and optimize the implantation
technique of this C-HA scaffold already applied in the clinical
practice. Literature analysis shows that clinical studies on this C-HA
scaffold reported an overall good outcome but also some contro-
versial aspects15e21 that might be, at least in part, explained by this
experiment. An insufﬁcient ﬁxation coupled with an aggressive
rehabilitation might lead to scaffold damage, delamination, syno-
vitis induced byHA release, and even implant failure. To avoid these
problems and further improve the initial positive clinical results,
ﬁbrin glue is an option to increase the press-ﬁt stability of this
scaffold.
Scaffold ﬁxation can be obtained with several methods: press-ﬁt
only or intrinsic adhesive scaffold properties, ﬁbrin glue, suture, pin
ﬁxation22e24. Whereas some authors suggest a low mechanical
stabilization of ﬁbrin glue, inferior with respect to other more
invasive options25 (which on the other hand present problems such
asmore cumbersome procedures and risk of further iatrogenic joint
damage23), others show that ﬁbrin glue still offers an additional
ﬁxation andmay signiﬁcantly improve the early ﬁxation rate22,26,27.
To evaluate the contribution of ﬁbrin glue to ﬁxation a human
cadaver model was used as introduced by Drobnic et al.22 and
Bekkers et al.23, who compared the stability and ﬁxation of thinner
chondral scaffolds in a condition comparable to the post-operative
phase. This ex-vivo study allowed a precise comparison of the twoFig. 8. Two possible failure mechanisms of press-ﬁt implanted scaffolds without ﬁbrin glu
with destruction of the cartilage layer (right).ﬁxation techniques directly in the same setting, thus demon-
strating the additional value of ﬁbrin glue ﬁxation. The key role of
ﬁbrin glue in enhancing mechanical ﬁxation and therefore scaffold
stability and integrity was clearly shown in all experimental con-
ditions. Statistically better scores were obtained in all locations,
MFC, LFC, and trochlea, and with both the three-layer scaffold and
the thinner bi-layer version. The bi-layer version has been devel-
oped aiming to treat shallower defects, where the subchondral
bone is still involved, but that require a less deep lesion preparation
to remove the degenerated layer and expose vital subchondral
bone. Interestingly the two incontrovertible failures both occurred
in LFCs treated with the bi-layer scaffold, whichmight be explained
by unfavorable conditions due to a combination of defect shoulder
depth and curvature of the articular surface. However, regardless of
the failure characteristics, the contribution of ﬁbrin glue to scaffold
stability was shown to be critical in all conditions. After applying
ﬁbrin glue the implants improved both in terms of intrinsic layer
cohesiveness and ﬁxation strength at the articular surface. This
ﬁnding has two major consequences, one is understanding the
behavior of the scaffold described in the current literature, and the
other in suggesting a better implant technique and post-operative
management. Understanding press-ﬁt implanted scaffold behavior
mainly regards the possible mechanisms of failure. It is of particular
interest to notice that two out of 16 condyles failed, making a 12.5%,
rate which is similar to the 13.3% imaging ﬁndings of partial
detachment reported in a previous MRI early stability evaluation
study21. Two failure mechanisms can be hypothesized: the entiree: deformation, bending, and dislodgment of the entire scaffold (left) or delamination
G. Filardo et al. / Osteoarthritis and Cartilage 22 (2014) 557e565 563osteochondral scaffold can be deformed and dislodged, thus lead-
ing to a loose body, or the superﬁcial layer can be altered with
delamination and disruption of the cartilage-like surface. This
second mechanism might be more difﬁcult to detect, since the
damage or loss of the upper layer might be much more difﬁcult to
observe by MRI with respect to a completely empty defect after
implant detachment. The characteristics that might lead to the two
failure patterns cannot be precisely demonstrated, but it is likely
that a role is played by the articular site (with peculiar surface
curvature and mechanical stresses), since it was more likely to ﬁnd
the former at the trochlea level, whereas delamination was
observed mainly at the condyle level. Regardless of the modality,
these mechanisms have the exposure of the lower layers and
therefore the release of HA in the joint environment in common,
which can still cause, if not a failure, swelling and temperature28,29,
which are adverse events responsible for a slower clinical
improvement. This aspect also leads to repercussions of the study
results on surgical and postsurgical patient management. In fact,
whereas the press-ﬁt implantation might cause a lack of stability
with slow scaffold integration and post-operative adverse events,
which have been shown to affect the clinical outcome up to 2 years
of follow-up16, a stable implant allows a safer and faster rehabili-
tation. Fibrin glue ﬁxation would allow an early mobilization that
both would remove the ﬁbrin glue layer in excess (preventing
adhesion formation) and would allow a safer progressive load. In
fact, in the treatment of musculoskeletal injuries one of the most
important developments has been the understanding that
controlled early resumption of activity can promote restoration of
function30. Joint movement and weight bearing are necessary for
tissue homeostasis, by ensuring nutrition and maintaining biome-
chanical properties of normal cartilage. In vitro studies have shown
that mechanical forces affect cell biosynthesis and gene expres-
sion31,32. The repair tissue after scaffold implantation is also
exposed to a remodeling process and thus susceptible to mechan-
ical stimuli. Moreover, a fast rehabilitation might not just shorten
the implant maturation time, but might also reduce the initial
complications due to immobilization and inactivity and even
signiﬁcantly improve the ﬁnal long-term clinical outcome33. Of
course, the implant is most vulnerable during the initial stage and
should be protected by avoiding peak compressive and shearing
forces34. However, the results of the present study show that ﬁbrin
glue stabilizes the implant, thus allowing a safe early mobilization,
and even slight joint loading resembling the toe-touch weight
bearing does not seem to jeopardize the implant. It would therefore
seem a reasonable assumption that the increased mechanical sta-
bility with the addition of ﬁbrin glue might allow safe management
and probably speed up the immediate post-operative period, and
might even optimize the results of surgery. The following study
limitations need to be acknowledged: short post-implantation
testing time, ex-vivo nature of the study, which lacks information
on the intra-articular biology on scaffold stability, and limited
sample size. However, the 60-cycle testing time was selected ac-
cording to a previous study showing that the effect of mobilization
on scaffold stability and integrity, as well as failures, were detected
at this time point, whereas further mobilization cycles did not offer
any further information. The toe-touch weight bearing was simu-
lated only in two knees and only when the scaffold was ﬁxed with
ﬁbrin glue. There was no reason to stress the press-ﬁt implant
further, since the CPM mobilization already clearly outlined the
criticalities of this ﬁxation. Lesions were not large, but they are
similar to those reported for large cartilage treatment data-
bases24,35. Moreover, smaller lesions should in theory favor the
shoulder protection of the graft: therefore, the highly signiﬁcant
results should make the positive effect of ﬁbrin glue plausible also
for bigger lesions. The main limitation of this study is the puremechanical investigation of the ﬁxation modality. In fact, whereas
there is incontrovertible evidence on the mechanical advantage of
ﬁbrin glue both in terms of scaffold stability and protection, we do
not know the biological interaction in the living joint environment.
In spite of the ex-vivo model, fresh blood from the by-standing
donor was applied to the lesion to simulate natural ﬁxation and
cohesive element acting on the scaffold in vivo immediately after
implantation. Another aspect that cannot be explored by this model
is that ﬁbrin glue might obstruct the migration of mesenchymal
stem cells from the surrounding subchondral bone, as well as the
ﬂow of nutrients, and therefore might affect the initial integration
and maturation phases. However, this is an unlikely situation, since
ﬁbrin glue has been used in cartilage treatments for decades and
recently has even been suggested as a suitable scaffold for chon-
drocyte transplantation11,36e38. In this light, ﬁbrin glue might favor
implant integration not only mechanically, but also biologically, by
representing a scaffold itself to host cells and promote tissue for-
mation at the hostescaffold interface. Whereas the biological effect
of ﬁbrin glue has to be further explored through preclinical in vivo
studies, it has to be underlined that scaffold stability is a prereq-
uisite for the success of an implant. Thus, until other studies in-
crease the knowledge on the initial phases of implant integration
and maturation and give further indications on the most appro-
priate surgical technique, the results of this study strongly support
the use of ﬁbrin glue for the implantation of these bi or three-layer
C-HA osteochondral scaffolds.
Conclusion
An evaluation of press-ﬁt implanted scaffolds showed that
scaffold swelling due to interaction with biologic ﬂuids is not ho-
mogeneous, resulting in the loss of press-ﬁt at the cartilage level
and exposure of the lower C-HA structure directly at the intra-
articular space, other than delamination and dislodgment. These
problems were never observed when using ﬁbrin glue, which sta-
bilized the scaffold both by increasing its internal layer cohesive-
ness and integrity in the lesions area. This cadaveric study showed
that ﬁbrin glue notably improved the press-ﬁt ﬁxation of bi-layer or
three-layer C-HA scaffolds regardless of lesion location. It is
therefore recommended that ﬁbrin glue be used during surgery to
improve early post-operative C-HA scaffold stability and integrity.
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